Cargando…
The structure of blood–tumor barrier and distribution of chemotherapeutic drugs in non-small cell lung cancer brain metastases
BACKGROUND: Brain metastasis is an important cause of increased mortality in patients with non-small cell lung cancer (NSCLC). In brain metastasis, the blood–brain barrier (BBB) is frequently impaired, forming blood–tumor barrier (BTB). The efficacy of chemotherapy is usually very poor. However, the...
Autores principales: | Ye, Ling-yun, Sun, Li-xiang, Zhong, Xiu-hua, Chen, Xue-song, Hu, Song, Xu, Rong-rong, Zeng, Xiao-ning, Xie, Wei-ping, Kong, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543815/ https://www.ncbi.nlm.nih.gov/pubmed/34689774 http://dx.doi.org/10.1186/s12935-021-02263-6 |
Ejemplares similares
-
The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017) -
An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021) -
The chemotherapeutic agent bortezomib induces the formation of stress granules
por: Fournier, Marie-Josée, et al.
Publicado: (2010) -
Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines
por: Cui, Hai, et al.
Publicado: (2014) -
Transcription factor E2F3a regulates CASP8AP2 transcription and enhances sensitivity to chemotherapeutic drugs in acute lymphoblastic leukemia
por: Liu, Fei-Fei, et al.
Publicado: (2018)